MREO CIK: 1719714

Mereo BioPharma Group plc

  • United Kingdom
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
75.2
FY23:
63.8
FY24:
74.8
FY25:
45.0
(positive)
Change from FY22 to FY25
millions USD
FY22:
2.22
FY23:
2.74
FY24:
1.63
FY25:
0.90
Total assets
Change from FY22 to FY25
millions USD
FY22:
77.4
FY23:
66.5
FY24:
76.4
FY25:
45.9

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
24.4
FY23:
9.49
FY24:
13.8
FY25:
4.30
(negative)
Change from FY22 to FY25
millions USD
FY22:
1.64
FY23:
6.48
FY24:
1.57
FY25:
0.70
(positive)
Change from FY22 to FY25
millions USD
FY22:
51.4
FY23:
50.5
FY24:
61.0
FY25:
40.9
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
77.4
FY23:
66.5
FY24:
76.4
FY25:
45.9

All amounts in millions USD Data source:SEC EDGAR